# Phase K.4.0 — Pilot Environment Validation Authorization

**STATUS:** AUTHORIZED
**DATE:** 2026-01-21
**CONTROL CLASSIFICATION:** EXECUTION-AUTHORIZATION

## 1. PURPOSE

This document formally authorizes the validation of the pilot environment following the successful verification and locking of the application runtime in Phase K.3.1. It provides the mandate for controlled, synthetic validation activities required to confirm that all security, governance, and operational controls are effective before any business traffic is permitted.

## 2. REFERENCES

This authorization is issued under the authority of the following locked governance artifacts:
- **Phase K.3.1:** Application Runtime Verification Lock
- **Phase J.7.x:** Runtime Governance
- **Phase J.8.x–J.9.x:** Authorization & Audit
- **Phase J.11.x:** Compliance Consolidation

## 3. AUTHORIZED SCOPE (EXPLICIT)

This phase authorizes the following activities ONLY:
- **Controlled Validation:** Non-business validation activity against the deployed and locked runtime environment.
- **Synthetic Contexts:** Use of synthetic requests, test identities, and non-production authority contexts.
- **Control Validation:** Verification of:
    - Authorization enforcement across all service boundaries.
    - Audit emission completeness and integrity.
    - Strict tenant isolation and data boundary enforcement.
    - Error handling and fail-closed behavior under stress or invalid inputs.
    - Health, readiness, and resilience characteristics of the deployed workloads.
- **Data Constraint:** Validation activity MUST NOT involve real users, real customer data, or real clinician access.

## 4. EXPLICIT PROHIBITIONS (MANDATORY)

The following activities are STRICTLY FORBIDDEN during Phase K.4.0:
- **NO Business Traffic:** Real business traffic or operational workloads are prohibited.
- **NO User Access:** Real customer or clinician access to the environment is forbidden.
- **NO Production Identities:** Use of production credentials, identities, or authority tokens is prohibited.
- **NO PHI/PII:** Persistence or processing of Protected Health Information (PHI) or Personally Identifiable Information (PII) in any form is forbidden.
- **NO Data Persistence:** Data persistence is limited to ephemeral test artifacts; long-term business data storage is prohibited.
- **NO Schema Mutation:** Schema migrations, data backfills, or structural data changes are forbidden.
- **NO External Exposure:** Public announcements, external documentation releases, or exposure to unauthorized parties is prohibited.
- **NO SLA Commitments:** No SLA, uptime, or performance commitments are authorized for this environment.

## 5. SAFETY INVARIANTS

The following invariants MUST be maintained throughout the validation window:
- **Fail-Closed Enforcement:** All validation activity MUST be fail-closed; any security or logic failure must result in denied access.
- **No Bypasses:** Validation failures MUST NOT be bypassed or manually overridden.
- **Halt on Deviation:** Any deviation from the authorized state or expected control behavior requires an immediate halt or rollback; remediation-in-place is forbidden.
- **Auditable Evidence:** All validation activity must generate immutable, auditable evidence for review in the subsequent verification phase.

## 6. PHASE BOUNDARY

- **Phase K.4.0** authorizes VALIDATION ONLY.
- **No traffic enablement** or operational usage is permitted under this authorization.
- **NEXT PHASE:** **Phase K.4.1 — Pilot Environment Validation Verification Lock**

## 7. LOCK STATEMENT

- This authorization is FINAL and IMMUTABLE once committed.
- Any pilot traffic or further environment progression requires the successful completion and locking of **Phase K.4.1**.

---
**AUTHORIZATION GRANTED: GOVERNANCE AGENT**
